Total investments

213

Average round size

2M

Portfolio companies

188

Rounds per year

4.02

Lead investments

68

Follow on index

0.11

Exits

9

Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceMachine LearningHealth CareManufacturingMedical DeviceMedicalInternet of Things

Summary

We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Health Care. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline DNA Script, Sol Voltaics, Infarm Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The common things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2019. The fund is generally included in 25-48 deals every year. Comparing to the other companies, this Horizon 2020 performs on 25 percentage points less the average number of lead investments. The important activity for fund was in 2019. Speaking about the real fund results, this Corporate Investor is 41 percentage points more often commits exit comparing to other organizations. The typical startup value when the investment from Horizon 2020 is 1-5 millions dollars.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Horizon 2020, startups are often financed by Venture Kick, Tekes, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are EASME - EU Executive Agency for SMEs, Tekes, Maki.vc. In the next rounds fund is usually obtained by European Bank for Reconstruction and Development, EIT Health, UCLB.

Show more

Investments analytics

Analytics

Total investments
213
Lead investments
68
Exits
9
Rounds per year
4.02
Follow on index
0.11
Investments by industry
  • Biotechnology (54)
  • Health Care (52)
  • Software (42)
  • Medical Device (41)
  • Medical (35)
  • Show 214 more
Investments by region
  • United Kingdom (29)
  • Denmark (7)
  • France (8)
  • Spain (26)
  • Netherlands (12)
  • Show 19 more
Peak activity year
2019
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
16M
Group Appearance index
0.19
Avg. company exit year
13
Avg. multiplicator
1.54
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Feastie 07 Mar 2012 Food and Beverage, Hospitality Seed 0 United States, District of Columbia, Washington
LatinoPro 10 Nov 2017 Information Technology, Human Resources, Staffing Agency Seed 180K United States, Wisconsin, Milwaukee
MUVON Therapeutics 31 May 2021 Biotechnology, Health Care, Life Science Early Stage Venture Zürich, Switzerland, Zurich
Ovon Home 01 Oct 2020 Software, Information Technology, Hardware, Internet of Things, Energy, Energy Efficiency Seed 73K England, Manchester, United Kingdom
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.